EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology

Aaron S Devanathan iD, Thomas D Nolin iD

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Aaron S Devanathan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy & Therapeutics, Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsyl…. Hauptthemen laut MEDLINE: HIV Infections, Metabolic Syndrome, Anti-HIV Agents, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As antiretroviral therapy (ART) prolongs lifespans, people with HIV (PWH) face a new syndemic: Cardiovascular‐Kidney‐Metabolic (CKM) syndrome. Yet CKM in PWH is poorly characterized. Inflammation, complex pharmacokinetic (PK) alterations, ART‐associated metabolic effects, and gut dysbiosis amplify risk. Managing CKM increases medication burden, thereby heightening the risk of drug–drug interactions and adverse drug effects. Therefore, CKM in PWH represents an emerging clinical pharmacology priority. We outline gaps and challenges and call for CKM research in PWH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsMetabolic SyndromeAnti-HIV AgentsCardiovascular DiseasesHumansPharmacology, ClinicalDrug Interactions

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Pharmacy & Therapeutics, Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Aaron S Devanathan, Thomas D Nolin

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Devanathan, A. S., & Nolin, T. D. (2026). Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70164

Vancouver

Devanathan AS, Nolin TD. Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70164

BibTeX
@article{Devanathan2026,
  author = {Devanathan, Aaron S and Nolin, Thomas D},
  title = {Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70164}
}
Kostenlos starten →